SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-008670
Filing Date
2024-03-04
Accepted
2024-03-04 11:01:33
Documents
14
Period of Report
2024-03-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40481
  Complete submission text file 0001493152-24-008670.txt   212177

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indp-20240304.xsd EX-101.SCH 3021
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indp-20240304_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indp-20240304_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3392
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 24713370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)